IQMD Intelligent Medicine Acquisition Corporation

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF

THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER

SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number: 001-41024

 

INTELLIGENT MEDICINE ACQUISITION CORP.

(Exact name of registrant as specified in its charter)

 

9001 Burdette Rd.
Bethesda, MD 20817

(202) 905-5834

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Units, each consisting of one share of Class A common stock and one-half of one warrant

Class A common stock, par value $0.0001 per share

Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50

(Title of each class of securities covered by this Form)

 

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)	x
Rule 12g-4(a)(2)	¨
Rule 12h-3(b)(1)(i)	x
Rule 12h-3(b)(1)(ii)	¨
Rule 15d-6	¨
Rule 15d-22(b)	¨

 

Approximate number of holders of record as of the certification or notice date: 3

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Intelligent Medicine Acquisition Corp. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

 

 

	INTELLIGENT MEDICINE ACQUISITION CORP.
Date: May 12, 2023	By:	/s/ Gregory C. Simon
		Name:	Gregory C. Simon
		Title:	Chief Executive Officer